Audit of cervical cancer chemoradiation guideline compliance across National Cancer Grid centers
Official title: Compliance to Cervical Cancer Chemoradiation Guidelines: A Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India
Run by Tata Memorial Hospital · NCT07290972 · Data updated 2026-11-12
This project will check how closely hospitals across India follow recommended chemoradiation treatments for patients with cervical cancer.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Women only |
| Enrollment | 618 (estimated) |
| Sponsor | Tata Memorial Hospital Government |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Mumbai, Maharashtra and 1 other locations) |
| Status | Recruiting |
| Started | February 1, 2021 |
| Main results expected | March 31, 2026 |
| Study ends | March 31, 2026 |
| Registry record updated | February 4, 2026 |
| Trial ID | NCT07290972 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Patients eligible are those with histologically proven cervical cancer who were planned to receive radical, adjuvant, or palliative radiation with or without concurrent or systemic chemotherapy, or who were referred for brachytherapy, during the participating center's six-month capture period.
✕Probably not a fit
Individual patients should not expect direct therapeutic benefit from participation, and patients enrolled in other prospective clinical trials are excluded from this audit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter observational audit will collect de-identified retrospective and prospective data from participating National Cancer Grid institutions over a six-month period to document whether definitive, adjuvant, palliative radiation and concurrent chemotherapy meet guideline recommendations. Patients enrolled in other prospective treatment trials are excluded, while cases referred for brachytherapy alone are included. Data will be entered via a shared electronic case record form (Google e-form) that exports standardized outputs to facilitate pooled analysis and resource assessment. The initiative aims to map compliance, identify system-level gaps, and inform targeted implementation efforts across diverse resource settings in India.
Why it matters
Potential benefit: If successful, the audit could reveal gaps in care and guide quality-improvement efforts that improve adherence to guideline-based chemoradiation and thereby patient outcomes.
How similar studies have gone: Previous oncology audits and implementation programs have shown that systematic audits and guideline dissemination can improve adherence, though comprehensive nationwide compliance data for cervical chemoradiation in India remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
The participating centers that agree to contribute data will include all registered cases over a 6 month period that have been diagnosed with histologically proven cervical cancer wherein either radical, adjuvant or palliative radiation with or without concurrent or systemic chemotherapy is planned. Furthermore any cases referred to the institution for brachytherapy alone will also be included.
Where it's running
-
Tata Memorial Hospital
Mumbai, Maharashtra, India Recruiting -
Tata Memorial Hospital
Mumbai, Maharashtra, India Recruiting
Study contacts
- Principal investigator: Dr. Supriya Chopra, MD — ACTREC, Tata Memorial Centre, Navi Mumbai India
- Study coordinator: Dr. Supriya Chopra, MD
- Email: supriyasastri@gmail.com
- Phone: 9930958309
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Immunonutrition and Brain Monitoring to See if Delirium Happens After Gynecologic Cancer Surgery
This study tests whether a preoperative immunonutrition scoring plus intraoperative brain monitoring can help predict or relate to postoperative delirium in women aged 65 and older undergoing major gynecologic cancer surgery.
-
Risk of cervical cancer after HPV detection in healthy women
This study tests how likely it is for cervical cancer to develop after different HPV detection patterns in healthy women who undergo HPV-based screening.
-
Routine shallow-coverage Whole Genome Sequencing of Cervical Smears to See if Ovarian Cancer is Found Earlier
Researchers test whether analyzing DNA from cervical smears with shallow whole-genome sequencing can help detect high-grade serous ovarian cancer early in patients undergoing treatment for this cancer.
-
Prophylactic subcutaneous drainage after gynecologic cancer surgery
This study tests whether placing a small drain under the skin after gynecologic cancer surgery helps prevent wound problems in women with thicker tissue under the skin.
-
HPV self-sampling in the ED to screen under-screened women
This study tests whether giving an HPV self-sampling kit in the emergency department can help under-screened women get screened for cervical cancer and find those with HPV to guide follow-up care.
-
Feasibility of high-dose multimodal prehabilitation for women awaiting gynecologic cancer surgery
This study tests whether a high-dose, multimodal prehabilitation program can be delivered before gynecologic cancer surgery and whether patients prefer in-person, remote, or education-only approaches.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.